Research2Guidance January 29, 2024
Ralf-Gordon Jahns

GLP-1 companion apps are a win-win for pharma, health plans, behavior change app publishers and patients. Major weight loss app publishers have added GLP-1 specific programs to their portfolios. National health systems and health plans started to make companion solutions mandatory. Other companion solution providers should monitor progress of these solutions closely and adopt.

GLP-1 (Glucagon-like peptide-1) apps are designed to support individuals who are prescribed GLP-1 receptor agonists, a class of medications commonly used to treat type 2 diabetes. These apps typically offer features that help users manage their diabetes, monitor their GLP-1 therapy, and make lifestyle choices that support overall health.

Recently GLP-1 drugs became the weight loss drug for people in mainly western countries to efficiently lose...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Biotechnology, Digital Health, Pharma, Pharma / Biotech, Technology
Medicare insurers ranked by mobile app quality
How an App Store Approach Fuels Innovation and Efficiency in Healthcare
'The generation that created the internet is now our audience': SCAN Group prepares to launch first mobile app
Appleā€™s Vision Pro has a problem a year into its existence: Not enough apps
Research reveals concerning links between fitness apps and disordered eating

Share This Article